Literature DB >> 8601100

Adjuvant treatment for colorectal cancer.

M L Slevin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8601100      PMCID: PMC2350050          DOI: 10.1136/bmj.312.7028.392

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  9 in total

1.  Survival after postoperative combination treatment of rectal cancer.

Authors:  H O Douglass; C G Moertel; R J Mayer; P R Thomas; A S Lindblad; A Mittleman; D M Stablein; H W Bruckner
Journal:  N Engl J Med       Date:  1986-11-13       Impact factor: 91.245

2.  Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01.

Authors:  N Wolmark; B Fisher; H Rockette; C Redmond; D L Wickerham; E R Fisher; J Jones; A Glass; H Lerner; W Lawrence
Journal:  J Natl Cancer Inst       Date:  1988-03-02       Impact factor: 13.506

3.  Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.

Authors:  J A Laurie; C G Moertel; T R Fleming; H S Wieand; J E Leigh; J Rubin; G W McCormack; J B Gerstner; J E Krook; J Malliard
Journal:  J Clin Oncol       Date:  1989-10       Impact factor: 44.544

4.  The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03.

Authors:  N Wolmark; H Rockette; B Fisher; D L Wickerham; C Redmond; E R Fisher; J Jones; E P Mamounas; L Ore; N J Petrelli
Journal:  J Clin Oncol       Date:  1993-10       Impact factor: 44.544

5.  Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report.

Authors:  C G Moertel; T R Fleming; J S Macdonald; D G Haller; J A Laurie; C M Tangen; J S Ungerleider; W A Emerson; D C Tormey; J H Glick; M H Veeder; J A Mailliard
Journal:  Ann Intern Med       Date:  1995-03-01       Impact factor: 25.391

6.  Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.

Authors:  C G Moertel; T R Fleming; J S Macdonald; D G Haller; J A Laurie; P J Goodman; J S Ungerleider; W A Emerson; D C Tormey; J H Glick
Journal:  N Engl J Med       Date:  1990-02-08       Impact factor: 91.245

7.  The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer.

Authors:  P G Johnston; E R Fisher; H E Rockette; B Fisher; N Wolmark; J C Drake; B A Chabner; C J Allegra
Journal:  J Clin Oncol       Date:  1994-12       Impact factor: 44.544

8.  Effective surgical adjuvant therapy for high-risk rectal carcinoma.

Authors:  J E Krook; C G Moertel; L L Gunderson; H S Wieand; R T Collins; R W Beart; T P Kubista; M A Poon; W C Meyers; J A Mailliard
Journal:  N Engl J Med       Date:  1991-03-14       Impact factor: 91.245

9.  Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group.

Authors:  G Riethmüller; E Schneider-Gädicke; G Schlimok; W Schmiegel; R Raab; K Höffken; R Gruber; H Pichlmaier; H Hirche; R Pichlmayr
Journal:  Lancet       Date:  1994-05-14       Impact factor: 79.321

  9 in total
  3 in total

1.  Adjuvant treatment for colorectal cancer. Reducing avoidable delays in establishing the diagnosis is also important.

Authors:  G Aithal; A Tanner
Journal:  BMJ       Date:  1996-06-01

2.  Adjuvant treatment for colorectal cancer. Concerns about chemotherapy are legitimate.

Authors:  R Gray; J Northover
Journal:  BMJ       Date:  1996-06-01

3.  Colorectal cancer pathology reporting: a regional audit.

Authors:  A D Bull; A H Biffin; J Mella; A G Radcliffe; J D Stamatakis; R J Steele; G T Williams
Journal:  J Clin Pathol       Date:  1997-02       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.